Saturday, December 21, 2024
12/21/2024
Herpes simplex virus type 2 (HSV-2) is a major driver of the HIV epidemic, but the underlying biological mechanisms have not been delineated. Recurrent HSV-2 shedding, which occurs more often in HIV-infected persons, is characterized by the recruitment and persistence of CD4+ T cells and other immune cells at sites of HSV-2 reactivation as well as an increase in activated CD4+ T cells in the peripheral blood. These findings prompted us to test the hypothesis that HSV-2 induces transcriptional changes in CD4+ T cells that promote HIV replication and/or reactivation. We exposed primary CD4+ T cells or a latently HIV-infected T cell line to HSV-2 and, using RNA sequencing, identified significant transcriptional changes both in the HSV-2 infected and bystander cells. Importantly, the transcriptional changes were associated with an increase in HIV replication and reactivation. One of the most significant responses we observed in both HSV-2 infected and bystander cells was an increase in expression of the long noncoding RNA, MALAT1. MALAT1 impacts the expression of multiple transcripts including the HIV long terminal repeat (LTR) through interactions with the Polycomb Repressive Complex 2 (PRC2). We knocked out MALAT1 in an HIV-latently infected cell line and showed that HIV latency reversal was significantly reduced but not abolished when the knockout compared to the parental cells were infected with HSV-2. Building on this foundation, we propose to further define MALAT1-mediated and identify MALAT1-independent mechanisms by which HSV-2 promotes HIV replication and reactivation. We will take advantage of a longitudinal biorepository of peripheral blood mononuclear cells from people living with HIV and compare the responses to HSV-2 during periods of HIV viremia and viral suppression. We will expose the cells to HSV-2 and conduct single cell RNA sequencing, proteomic and histone analyses and determine how the cellular responses to HSV-2 enhance HIV replication and promote HIV latency reversal. We will then focus on changes at the site of HSV-2 reactivation using genital skin biopsies collected at the time of an HSV outbreak (lesion and unaffected tissue) and after resolution in HIV-infected and uninfected individuals. This will also allow us to assess interactions between different cell types including epithelial cells, which are primary targets of HSV replication. We will use cutting-edge high resolution spatial technologies to identify gene and protein expression in the tissue. Results of these studies have great translational relevance and will identify new targets to promote or prevent HIV latency reversal that can ultimately lead to HIV eradication.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).